Recombinant adenoviral vectors and applications thereof
US8119396B2 · kind B2 · utility
4Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2003 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Nov 11, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10352
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant adenoviruses or pseudoviruses having a deletion of all or part of the region of the adenovirus genome corresponding to nucleotides 311 to 499 in canine adenovirus type 2 (GeneBank J04368). Therapeutic methods of using the recombinant adenovirus or pseudovirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.